Navigation Links
Realizing the promise of RNA nanotechnology for new drug development
Date:9/4/2012

New Rochelle, NY, September 4, 2012The use of RNA in nanotechnology applications is highly promising for many applications, including the development of new therapeutic compounds. Key technical challenges remain, though, and the challenges and opportunities associated with the use of RNA molecules in nanotechnology approaches are presented in a review article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. The article is available free online at the Nucleic Acid Therapeutics website.

Peixuan Guo and colleagues, University of Kentucky, Lexington, highlight the ability of RNA to self-assemble into nanoparticles with diverse structures. In "Uniqueness, Advantages, Challenges, Solutions, and Perspectives in Therapeutics Applying RNA Nanotechnology," the authors provide a detailed description of the main challenges faced by the RNA therapeutics industry, including the chemical and thermodynamic instability of the molecules, potential safety and side effect issues, difficulties in delivery and specific targeting, and low yield and high production costs in manufacturing.

"The remarkable structural and enzymatic properties of RNA continue to astound us," says Executive Editor Fintan Steele, PhD, SomaLogic, Inc., Boulder, CO. "It is exciting to see those properties increasingly realized for the benefit of human health and welfare, as described by Dr. Guo and his colleagues."


'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100 x2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Page: 1

Related biology news :

1. KIT researchers succeed in realizing a new material class
2. New study shows promise in using RNA nanotechnology to treat cancers and viral infections
3. Silicone foul release coatings show promise to manage invasive mussels at water facilities
4. Common antifungal drug decreases tumor growth and shows promise as cancer therapy
5. New drug shows promise for kidney disease
6. Nanoscale scaffolds and stem cells show promise in cartilage repair
7. New compound holds promise for treating Duchenne MD, other inherited diseases
8. A sea of broken promises
9. New stem cell technique promises abundance of key heart cells
10. Transcatheter aortic valve implantation shows promise in patients with severe aortic stenosis
11. Innovative cell printing technologies hold promise for tissue engineering R&D
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Realizing the promise of RNA nanotechnology for new drug development
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... - Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle ... around 15.1% over the next decade to reach approximately $1,580 million ... estimates and forecasts for all the given segments on global as ...
(Date:3/22/2017)... March 21, 2017 Vigilant Solutions , ... law enforcement agencies, announced today the appointment of retired ... of public safety business development. Mr. Sheridan ... experience, including a focus on the aviation transportation sector, ... recent position, Mr. Sheridan served as the Aviation Liaison ...
(Date:3/9/2017)... , March 9, 2017 4Dx has publicly ... Lung Imaging Workshop at the University of Pennsylvania. Founder ... to deliver the latest data to world leaders in ... brings together leaders at the forefront of the industry ... imaging. "The quality of the imaging ...
Breaking Biology News(10 mins):
(Date:4/27/2017)... and RESEARCH TRIANGLE PARK, N.C. ... (NASDAQ: UTHR ) today announced that its ... $250 million of the company,s common stock. This program ... December 31, 2017. Purchases may be made in the ... transactions from time to time as determined by United ...
(Date:4/27/2017)... Baltimore, MD (PRWEB) , ... April 27, 2017 ... ... analytics solutions provider for digital pathology, today announced their digital pathology technology has ... Using images provided by five medical centers in The Netherlands as part of ...
(Date:4/27/2017)... ... April 27, 2017 , ... This month ... (eConsent) solution that simplifies research studies, accelerates study startup, and improves participant engagement. ... Consent™ is the first and only IRB-integrated eConsent solution . , “Our ...
(Date:4/27/2017)... Ca (PRWEB) , ... April 27, 2017 , ... ... from a practicing internist, who will review how testing for 1,25-Dihydroxyvitamin D can ... prompt ordering of 25-OH-vitamin D and 1,25 dihydroxyvitamin D. , Dr. Gregory Plotnikoff, ...
Breaking Biology Technology: